Clinical trial Recruiting at 1 site Interventional Ages 18 to 55

Effects of lipid delivery on insulin resistance in muscle

Official title: Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids

Run by Mayo Clinic · NCT03818178 · Data updated 2026-11-12

This study is testing how different types of fats affect insulin resistance in the muscles of healthy adults to see if it can help us understand issues related to Type 2 diabetes.

More Insulin Resistance trials

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment60 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedDecember 1, 2018
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 12, 2026
Trial IDNCT03818178 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy, non-obese adults aged 18-65 with a BMI between 18 and 27.

Probably not a fit

Patients with ischemic heart disease, atherosclerotic valvular disease, or those on medications that alter lipid profiles may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how the delivery of different types of lipids affects insulin resistance in muscle tissue among healthy, non-obese adults. Participants will receive either an overnight infusion of palm oil or Intralipid, with a saline control, to assess how these lipids influence fatty acid trafficking and insulin signaling. The study aims to clarify the role of intramyocellular fatty acids in muscle insulin resistance, which is a key factor in conditions like Type 2 diabetes. By measuring changes in muscle fat storage and glucose disposal rates, the research seeks to provide insights into metabolic health.

Why it matters

Potential benefit: If successful, this study could lead to new strategies for managing insulin resistance and improving metabolic health in patients.

How similar studies have gone: While the specific approach of this study is novel, previous research has indicated that lipid profiles can significantly impact insulin sensitivity.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women and Men (Women premenopausal)
* BMI 18-27
* Weight stable
* Not pregnant/nursing

Exclusion Criteria:

* Ischemic heart disease
* Atherosclerotic valvular disease
* Smokers (\> 20 cigarettes per week)
* Bilateral oophorectomy
* Concomitant use of medications that can alter serum lipid profile (high dose fish oil, statins, niacin, fibrates, thiazolinediones, beta-blockers, atypical antipsychotics)
* Lidocaine allergy

Where it's running

  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.